Overview Recently Resected Patient Extending Adjuvant GLIVEC Recurrence Post Adjuvant Therapy Metastatic Patient With Progression After GI/Surgeon Diagnosis About GIST
Print
Font size:

GLIVEC CONTINUES TO REVOLUTIONIZE THE TREATMENT OF KIT+ GIST

Prior to GLIVEC (imatinib), the prognosis for patients with gastrointestinal stromal tumor (GIST) was poor. Tumor recurrence often followed surgical resection for primary disease. In advanced disease, there were no effective treatment options and survival averaged about 1 year.1,2

Today, data show 3 years of adjuvant GLIVEC is significantly reducing the risk of tumor recurrence following surgery for patients with KIT+ GIST, extending their lives with a 92% overall survival rate at 5 years.3 And, in the treatment of advanced KIT+ GIST, GLIVEC is extending the lives of patients to a median of nearly 5 years, even in the face of disease progression.3,4

Learn more about the benefit of extending adjuvant GLIVEC after KIT+ GIST resection.

GLIVEC: Positively Impacting the Lives of KIT+ GIST Patients

The patient cases to the right illustrate important clinical decision points in KIT+ GIST. Visit them to view information that can help you make informed treatment choices for your patients.

Select case now.

Prescribing GLIVEC

Review the safety profile of GLIVEC here, while getting the basics on dosing, administration, and ways to manage potential side effects.

Get the basics on dosing and administration for GLIVEC here.Prescribing GLIVEC

About GIST

Learn more about GIST, from its cellular origins through its clinical course, and see why a multidisciplinary approach optimizes patient care.

GIST=gastrointestinal stromal tumor.

KIT+ GIST:Recently
Resected Patient

Learn More Recently Resected Patient Image
Extending Adjuvant GLIVEC

Extending
Adjuvant GLIVEC

Learn More
Recurrence Post Adjuvant Therapy Patient Image

KIT+ GIST Recurrence
Post Adjuvant Therapy

Learn More
Metastatic Patient With Progression Patient Image

Metastatic KIT+ GIST
Patient With Progression

Learn More
After GI/Surgeon Diagnosis Patient Image

KIT+ GIST After
GI/Surgeon Diagnosis

Learn More

Prescribing
GLIVEC

Learn more

GLIVEC Product
Characteristics

View more

GLIVEC Safety
and Tolerability

Learn more

GLIVEC and KIT+ GIST

Glivec and Ph+ CML

Glivec and Additional Indications

For Your Patients

Library and Tools